Rua Bioscience Limited — Regulatory Filings 2020

Nov 5, 2020

MARKET ANNOUNCEMENT

==> picture [132 x 77] intentionally omitted <==

FOR PUBLIC RELEASE NZX Limited Wellington

5 November 2020

Rua Bioscience Commentary on Provisional Cannabis Referendum Results

The provisional result of the Cannabis Referendum announced on Friday 30 October has driven significant discussion in the media and in the community. The discussion has highlighted that the difference between medicinal cannabis and recreational cannabis is still not widely understood.

That lack of clarity has meant there has been an incorrect view that Rua Bioscience, which is a licenced Medicinal Cannabis company, is impacted by the outcome (either a yes vote or a no vote) of the Cannabis Referendum. This is not the case.

Ahead of the final result from the Cannabis Referendum being announced, the directors of Rua Bioscience believe it is important to clearly restate that the company’s strategy set out in the Product Disclosure Statement is to develop and primarily export pharmaceutical grade medicinal cannabis products.

Rua Bioscience has no plans to enter the recreational cannabis market if cannabis is legalised in New Zealand beyond the current provisions for medicinal cannabis.

Rua Bioscience is solely focussed on medicinal cannabis. Rua Bioscience is licenced under the Medicinal Cannabis Access Scheme, which came into effect on 1 April 2020. In August, Rua was granted one of the first commercial licences for cultivation, possession for manufacturing and supply of pharmaceutical cannabis.

ENDS

For shareholder enquiries please visit www.ruabio.com, or contact:

Rob Mitchell CEO, Rua Bioscience media@ruabio.com 0800 RUABIO

About Rua Bioscience : Rua Bioscience is a New Zealand pharmaceutical company aiming to be a leading producer of cannabinoid derived medicines for both export and local markets. Rua has been an early mover in the sector and was the first private company in New Zealand to receive a licence to cultivate cannabis for research purposes. Founded in 2017 in Ruatorea as a subsidiary of charitable company Hikurangi Enterprises Limited, Rua is underpinned by its mission to heal the people and heal the land. It is committed to New Zealand’s Te Tairāwhiti (East Coast) region and its connection

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com

with its local community. The company has completed facilities for cultivation and manufacturing and is currently going through the GMP certification process. www.ruabio.com

Rua Bioscience is trading under the name of Rua Bioscience Limited.

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com